ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Tezspire, Injektionslösung in einer Fertigspritze - 
68454001 AstraZeneca AG
Tezspire, Injektionslösung in einer Fertigspritze13.06.2022
  13.06.2022
Tezepelumab (R03DX11) 
WHO-DDD12.06.2027
03.04.50. 
03.04.50. 
B  
Yes 
IPCI
1036.42Yes
    
10 %1143.60
  
7680684540011Biotechnologika
  
Composition
tezepelumabum 210 mg, prolinum, acidum aceticum glaciale, polysorbatum 80, natrii hydroxidum q.s. ad pH, aqua ad iniectabile, ad solutionem pro 1.91 ml.
Packungsbestandteile
Injection solution in prefilled syringe 
  
 
Active AgentDose
Tezepelumabum210 mg
BAG: Active AgentDose
Tezepelumabum210 mg
 
Inactive agents
Acidum Aceticum Glaciale
Sodium Hydroxide
Polysorbatum 80
Proline
 
Source
Data was imported : 06.07.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home